202 related articles for article (PubMed ID: 31492474)
1. Evaluation of transcutaneous immunization as a delivery route for an enterotoxigenic E. coli adhesin-based vaccine with CfaE, the colonization factor antigen 1 (CFA/I) tip adhesin.
Rollenhagen JE; Woods CM; O'Dowd A; Poole ST; Tian JH; Guebre-Xabier M; Ellingsworth L; Prouty MG; Glenn G; Savarino SJ
Vaccine; 2019 Sep; 37(42):6134-6138. PubMed ID: 31492474
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity of a prototype enterotoxigenic Escherichia coli adhesin vaccine in mice and nonhuman primates.
Sincock SA; Hall ER; Woods CM; O'Dowd A; Poole ST; McVeigh AL; Nunez G; Espinoza N; Miller M; Savarino SJ
Vaccine; 2016 Jan; 34(2):284-291. PubMed ID: 26597148
[TBL] [Abstract][Full Text] [Related]
3. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
Byrd W; Boedeker EC
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
[TBL] [Abstract][Full Text] [Related]
4. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
[TBL] [Abstract][Full Text] [Related]
5. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Immunogenicity and Protective Efficacy of an Enterotoxigenic Escherichia coli CFA/I Adhesin-Heat-Labile Toxin Chimera.
O'Dowd A; Maciel M; Poole ST; Jobling MG; Rollenhagen JE; Woods CM; Sincock SA; McVeigh AL; Gregory MJ; Maves RC; Prouty MG; Holmes RK; Savarino SJ
Infect Immun; 2020 Oct; 88(11):. PubMed ID: 32839188
[TBL] [Abstract][Full Text] [Related]
7. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
[TBL] [Abstract][Full Text] [Related]
8. Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro.
Seo H; Nandre RM; Nietfeld J; Chen Z; Duan Q; Zhang W
PLoS One; 2019; 14(5):e0216076. PubMed ID: 31042746
[TBL] [Abstract][Full Text] [Related]
9. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
Ruan X; Liu M; Casey TA; Zhang W
Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and immunological characterization of an ETEC CFA/I adhesin cholera toxin B subunit chimera.
Jobling MG; Poole ST; Rasulova-Lewis F; O'Dowd A; McVeigh AL; Balakrishnan A; Sincock SA; Prouty MG; Holmes RK; Savarino SJ
PLoS One; 2020; 15(3):e0230138. PubMed ID: 32176708
[TBL] [Abstract][Full Text] [Related]
12. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.
Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.
Luo Q; Vickers TJ; Fleckenstein JM
Clin Vaccine Immunol; 2016 Jul; 23(7):628-37. PubMed ID: 27226279
[TBL] [Abstract][Full Text] [Related]
14. A first in human clinical trial assessing the safety and immunogenicity of transcutaneously delivered enterotoxigenic Escherichia coli fimbrial tip adhesin with heat-labile enterotoxin with mutation R192G.
Riddle MS; Maciel M; Porter CK; Poole ST; Gutierrez RL; Gormley R; Laird RM; Sebeny PJ; Dori KE; Greenleaf ME; Hoq F; Turiansky GW; Jarell A; Hawk D; Tribble D; Savarino SJ
Vaccine; 2020 Oct; 38(45):7040-7048. PubMed ID: 32978003
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
Zhang C; Zhang W
Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
[TBL] [Abstract][Full Text] [Related]
17. Establishment, Validation, and Application of a New World Primate Model of Enterotoxigenic
Rollenhagen JE; Jones F; Hall E; Maves R; Nunez G; Espinoza N; O'Dowd A; Prouty MG; Savarino SJ
Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30510102
[TBL] [Abstract][Full Text] [Related]
18. Protection of piglets against enteric colibacillosis by intranasal immunization with K88ac (F4ac) fimbriae and heat labile enterotoxin of Escherichia coli.
Lin J; Mateo KS; Zhao M; Erickson AK; Garcia N; He D; Moxley RA; Francis DH
Vet Microbiol; 2013 Mar; 162(2-4):731-739. PubMed ID: 23089483
[TBL] [Abstract][Full Text] [Related]
19. Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.
Zhang W; Sack DA
Clin Vaccine Immunol; 2015 Sep; 22(9):983-91. PubMed ID: 26135975
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Characterization of Immunogenicity and Efficacy against Diarrhea from MecVax, a Multivalent Enterotoxigenic E. coli Vaccine Candidate.
Seo H; Garcia C; Ruan X; Duan Q; Sack DA; Zhang W
Infect Immun; 2021 Jun; 89(7):e0010621. PubMed ID: 33875477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
